These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22583068)

  • 1. An ICD lead advisory: a plea for more diligence and more data.
    Kay GN; Ellenbogen KA
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):648-9. PubMed ID: 22583068
    [No Abstract]   [Full Text] [Related]  

  • 2. An analysis of implantable cardiac device reliability. The case for improved postmarketing risk assessment and surveillance.
    Laskey W; Awad K; Lum J; Skodacek K; Zimmerman B; Selzman K; Zuckerman B
    Am J Ther; 2012 Jul; 19(4):248-54. PubMed ID: 22668602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.
    Duggirala HJ; Herz ND; Caños DA; Sullivan RA; Schaaf R; Pinnow E; Marinac-Dabic D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):87-93. PubMed ID: 22095760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological effects of implantable cardioverter-defibrillator leads under advisory.
    Heatherly SJ; Simmons T; Fitzgerald DM; Mitchell M
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):694-9. PubMed ID: 21410721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic remote home monitoring of implantable cardioverter defibrillator lead and generator function: a system that tests itself everyday.
    Varma N
    Europace; 2013 Jun; 15 Suppl 1():i26-i31. PubMed ID: 23737225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings of the ICD Lead Performance Conference.
    Maisel WH; Hauser RG
    Heart Rhythm; 2008 Sep; 5(9):1331-8. PubMed ID: 18774113
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical device incident investigation.
    Baretich MF
    Biomed Sci Instrum; 2007; 43():302-5. PubMed ID: 17487098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening malfunction of implantable cardiac devices.
    Myerburg RJ; Feigal DW; Lindsay BD
    N Engl J Med; 2006 Jun; 354(22):2309-11. PubMed ID: 16702187
    [No Abstract]   [Full Text] [Related]  

  • 9. The Fidelis recall: how much pressure can the ICD world bear?
    Cannom DS; Fisher J
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1233-5. PubMed ID: 18811800
    [No Abstract]   [Full Text] [Related]  

  • 10. Detecting software failures in the MAUDE database: a preliminary analysis.
    Pecoraro F; Luzi D
    Stud Health Technol Inform; 2013; 192():1098. PubMed ID: 23920872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical judgment versus decision analysis for managing device advisories.
    Amin MS; Wood MA; Shepard RK; Kalahasty G; Ellenbogen KA
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1236-40. PubMed ID: 18811801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imperfect protection: syringe safety mechanisms can fail.
    Health Devices; 2003 May; 32(5):203-5. PubMed ID: 12827942
    [No Abstract]   [Full Text] [Related]  

  • 13. Living with an advisory ICD: how are the patients doing?--Actually just fine.
    Birnie DH; Keren A
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1004-5. PubMed ID: 19659619
    [No Abstract]   [Full Text] [Related]  

  • 14. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework?
    Basile EM; Lorell BH
    Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031
    [No Abstract]   [Full Text] [Related]  

  • 15. Product-experience reporting on endocardial defibrillation leads: a 4-year national perspective.
    Padeletti L; Pappone C; Curnis A; Zanotto G; Calò L; Ricciardi G; Pieragnoli P; Dondina C; Raciti G; Michelucci A
    Expert Rev Med Devices; 2009 Jul; 6(4):383-8. PubMed ID: 19572793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biventricular defibrillator patients have higher complication rates after revision of recalled leads.
    Brumberg GE; Kaseer B; Shah H; Saba S; Jain S
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):665-71. PubMed ID: 22519559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance.
    Auricchio A; Gropp M; Ludgate S; Vardas P; Brugada J; Priori SG;
    Europace; 2006 May; 8(5):313-22. PubMed ID: 16635986
    [No Abstract]   [Full Text] [Related]  

  • 18. Postmortem analysis and retrieval of implantable pacemakers and defibrillators.
    Kirkpatrick JN; Burke MC; Knight BP
    N Engl J Med; 2006 Apr; 354(15):1649-50. PubMed ID: 16611964
    [No Abstract]   [Full Text] [Related]  

  • 19. US Congress considers new tracking system for medical devices after excessive recalls.
    Epstein K
    BMJ; 2012 Apr; 344():e2915. PubMed ID: 22529316
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient-reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification.
    Pedersen SS; Versteeg H; Nielsen JC; Mortensen PT; Johansen JB
    Europace; 2011 Sep; 13(9):1292-8. PubMed ID: 21616945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.